Letter to "A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS)" by Ran Dan et al
- PMID: 28601468
- DOI: 10.1016/j.ijcard.2017.05.118
Letter to "A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS)" by Ran Dan et al
Keywords: Chinese; Lipid-lowering therapies; NSTE-ACS.
Comment on
-
A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin.Int J Cardiol. 2017 May 15;235:49-55. doi: 10.1016/j.ijcard.2017.02.099. Epub 2017 Feb 23. Int J Cardiol. 2017. PMID: 28291622 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
